Effect of some neonatal treatments on the hypothalamic-pituitary-adrenocortical function.
Ogawa
T
T
Division of Mental Disorder Research, National Institute of Neuroscience, NCNP, Kodaira.
Kuroda
Y
Y
Mikuni
M
M
Takahashi
K
K
D015116:5,7-Dihydroxytryptamine / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D001143:Arousal / Q000187:drug effects* / Q000502:physiology; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology; D002997:Clomipramine / Q000494:pharmacology*; D003345:Corticosterone / Q000097:blood; D003891:Desipramine / Q000494:pharmacology*; D003907:Dexamethasone / Q000494:pharmacology; D004644:Emotions / Q000187:drug effects* / Q000502:physiology; D005260:Female; D006624:Hippocampus / Q000187:drug effects / Q000502:physiology; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects* / Q000502:physiology; D008297:Male; D008426:Maternal Deprivation; D010913:Pituitary-Adrenal System / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D012149:Restraint, Physical / Q000523:psychology; D012701:Serotonin / Q000502:physiology; D013315:Stress, Psychological / Q000150:complications
D015116:5,7-Dihydroxytryptamine; D012701:Serotonin; D003907:Dexamethasone; D002997:Clomipramine; D003891:Desipramine; D003345:Corticosterone